Effects of the Proactive interdisciplinary self-management (PRISMA) program on self-reported and clinical outcomes in type 2 diabetes: a pragmatic randomized controlled trial

BMC Endocr Disord. 2019 Dec 11;19(1):139. doi: 10.1186/s12902-019-0466-0.

Abstract

Background: Diabetes self-management education can be helpful for patients with type 2 diabetes in managing their condition. We aimed to study the effects of the group-based PRoactive Interdisciplinary Self-MAnagement (PRISMA) training program on self-reported and clinical outcomes in patients with type 2 diabetes treated in general practice.

Methods: Persons aged 18 years or older diagnosed with type 2 diabetes and treated in primary care were included. In a randomized controlled trial design (1:1), patients were followed for 6 months with an extension phase of 6 months. Block randomization was used. The patients with type 2 diabetes received either PRISMA in addition to usual care or usual care only. All patients completed a range of validated questionnaires (including knowledge, skills, and confidence for self-management [PAM], diabetes self-care behavior [SDSCA], health-related quality of life [EQ-5D], and emotional well-being [WHO-5]). In addition, clinical outcomes (HbA1c, body mass index, systolic blood pressure, and cholesterol levels) were collected during the routine diabetes checkups.

Results: Of the total sample (n = 193), 60.1% were men. The mean age was 69.9 years (SD = 9.1). No significant differences were found on self-reported outcomes between the groups at 0, 6, and 12 months. The clinical outcomes were not reported due to a large number of missing values.

Conclusion: PRISMA did not improve self-reported outcomes in patients with type 2 diabetes treated in primary care. It was not possible to make a statement about the clinical effects.

Trial registration: date: 16/07/2014, number: NL4550 (https://www.trialregister.nl/trial/4550).

Keywords: E-health; Group education; Primary care; Self-management; Type 2 diabetes.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Aged
  • Body Mass Index
  • Diabetes Mellitus, Type 2 / therapy*
  • Female
  • General Practice
  • Glycated Hemoglobin / analysis
  • Health Behavior
  • Health Knowledge, Attitudes, Practice
  • Humans
  • Male
  • Middle Aged
  • Patient Education as Topic / methods*
  • Primary Health Care
  • Program Evaluation
  • Quality of Life
  • Reproducibility of Results
  • Self Report*
  • Self-Management / methods*
  • Surveys and Questionnaires
  • Treatment Outcome

Substances

  • Glycated Hemoglobin A